Norges Bank’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-407,075
| Closed | -$55.5M | – | 2202 |
|
|
2020
Q3 | $55.5M | Sell |
407,075
-274,738
| -40% | -$29.2M | 0.01% | 787 |
|
|
2020
Q2 | $65.9M | Sell |
681,813
-47,859
| -7% | -$3.99M | 0.02% | 681 |
|
|
2020
Q1 | $34.2M | Hold |
729,672
| – | – | 0.01% | 899 |
|
|
2019
Q4 | $53.2M | Hold |
729,672
| – | – | 0.01% | 870 |
|
|
2019
Q3 | $38.1M | Buy |
729,672
+323,207
| +80% | +$17.2M | 0.01% | 1043 |
|
|
2019
Q2 | $20.4M | Buy |
406,465
+21,199
| +6% | +$1.03M | 0.01% | 1492 |
|
|
2019
Q1 | $20M | Buy |
385,266
+117,404
| +44% | +$5.41M | 0.01% | 1508 |
|
|
2018
Q4 | $13.1M | Buy |
267,862
+121,342
| +83% | +$6.68M | ﹤0.01% | 1626 |
|
|
2018
Q3 | $9.55M | Buy |
+146,520
| New | +$8.62M | ﹤0.01% | 1827 |
|
|
2017
Q1 | – | Sell |
-67,142
| Closed | -$869K | – | 2203 |
|
|
2016
Q4 | $869K | Buy |
67,142
+57,142
| +571% | +$880K | ﹤0.01% | 2070 |
|
|
2016
Q3 | $156K | Buy |
+10,000
| New | +$181K | ﹤0.01% | 2136 |
|
|
2016
Q2 | – | Sell |
-4,080
| Closed | -$44K | – | 2203 |
|
|
2016
Q1 | $44K | Sell |
4,080
-2,620
| -39% | -$23.8K | ﹤0.01% | 2183 |
|
|
2015
Q4 | $98K | Buy |
+6,700
| New | +$81.9K | ﹤0.01% | 2220 |
|
Norges Bank's MYOK Position: Q4 2020 in Review
Norges Bank sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 407,075 shares — an estimated $55.5M sold.
Norges Bank first reported a position in MYOK in Q4 2015 and held it in 13 quarters. The position peaked at $65.9M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Norges Bank reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Norges Bank sold 407,075 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $55.5M.
- Norges Bank first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 13 quarters.
- Norges Bank's MyoKardia, Inc. Common Stock position peaked at $65.9M in Q2 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Norges Bank's 13F filing for Q4 2020, filed 10 Feb 2021.